The arylamine N-acetyltransferases as therapeutic targets in metabolic diseases associated with mitochondrial dysfunction.
Article in Pharmacological Reviews (December 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure
Article in Archives of Toxicology (August 2023)
The role of Mycobacterium tuberculosis acetyltransferase and protein acetylation modifications in tuberculosis
Article in Frontiers in Cellular and Infection Microbiology (July 2023)